As many as 8 in 10 people with Down syndrome develop Alzheimer’s disease.
The Trial-Ready Cohort-Down Syndrome, or TRC-DS, matches people with Down syndrome to clinical trials targeting Down-syndrome related Alzheimer’s disease. It is a national clinical study, and the Linda Crnic Institute for Down Syndrome is a qualified participation site near Denver, Colorado.
TRC-DS needs 120 healthy people between the ages of 35 and 55 with Down syndrome.
Because Alzheimer’s disease affects people with Down syndrome at a much earlier age than the general population, researchers are looking for volunteers 35 to 55 years old to participate in research.
According to the National Institutes of Health: Alzheimer’s disease is an irreversible brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks.
People with Down syndrome have an increased risk of death from Alzheimer’s disease, and by age 40, virtually all people with Down syndrome have a buildup of plaques in the brain, called amyloid, that leads to Alzheimer’s disease.
Now is the time to bring the latest discoveries in the Alzheimer’s field to the Down syndrome population!